Eunice Kwak, M.D., Ph.D.
Background
Eunice finds herself frequently nostalgic for freezing St. Louis winter nights spent waiting outside in line for Ted Drewes frozen custard along with the post-Blues hockey game crowd.
As VP Clinical Development, Eunice is the Global Medical Lead for the RLY-2608 program in oncology, leading the early- and late-phase development of RLY-2608 in breast cancer. Eunice is a medical oncologist with over a decade of experience caring for patients as an attending physician and early-phase clinical trial investigator at Massachusetts General Hospital. Always seeking transformative treatment options for patients, she transitioned to Novartis Institutes for Biomedical Research to lead Phase 1 trials primarily in immuno-oncology before her long-standing passion for precision medicine drew her to Relay Therapeutics.
Eunice holds a BAS and PhD from Stanford University and MD from Duke University. She completed training in Internal Medicine at Brigham and Women’s Hospital, and Medical Oncology at Dana Farber Cancer Institute and MGH.